Lv4
614 积分 2022-10-17 加入
Total Neoadjuvant Therapy With FOLFIRINOX Followed by Individualized Chemoradiotherapy for Borderline Resectable Pancreatic Adenocarcinoma
1天前
已完结
Phase I dose escalation study of capecitabine and erlotinib concurrent with radiation in locally advanced pancreatic cancer
1天前
已完结
Results of a Phase II Study on the Use of Neoadjuvant Chemotherapy (FOLFIRINOX or GEM/nab-PTX) for Borderline-resectable Pancreatic Cancer (NUPAT-01)
1天前
已完结
[Recommendations for diagnosis and treatment of systemic lupus erythematosus]
1个月前
已完结
Tegileridine: First Approval
2个月前
已完结
PDE5 inhibitors: targeting erectile dysfunction in diabetics
3个月前
已完结
The Lymphoma Epidemiology of Outcomes cohort study: Design, baseline characteristics, and early outcomes
3个月前
已完结
Waveline-001: Updated Results from a Phase 1 Dose Escalation and Cohort Expansion Study of Zilovertamab Vedotin (MK-2140) in Non-Hodgkin Lymphoma
3个月前
已完结
Mining the Microenvironment for Therapeutic Targets in Chronic Lymphocytic Leukemia
4个月前
已完结
Comparison of opioid‐free and opioid‐inclusive propofol anaesthesia for thyroid and parathyroid surgery: a randomised controlled trial
4个月前
已完结
皖公网安备34019202002308
